Frank Taffy
Founder bij SCHRÖDINGER, INC.
Oorsprong van het eerstegraads netwerk van Frank Taffy
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Packaged Software | 25 | |
Vuja De Sciences, Inc.
 Vuja De Sciences, Inc. Pharmaceuticals: MajorHealth Technology Vuja De Sciences, Inc. is engaged in biotechnology services. The company was founded by David Warshawsky, Rick Lampe, Robert E. Hurst and Raphael Nir and is headquartered in Hoboken, NJ.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Emtora Biosciences, Inc.
 Emtora Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Emtora Biosciences, Inc. operates as a drug development company which focuses on disease treatment and prevention through agents that modulate the mTor pathway in mammals. It produces drugs to slow the aging process and its efficacy in treating age-related diseases. The company was founded in 2012 and is headquartered in San Antonio, TX.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Helocyte, Inc.
 Helocyte, Inc. Miscellaneous Commercial ServicesCommercial Services Helocyte, Inc. engages in the development and commercialization of immunotherapies for the prevention and treatment of cytomegalovirus or CMV (cancer and infectious disease). It focuses on developing PepVax, a HLA-restricted single antigen peptide vaccine for controlling CMV in allogeneic hematopoietic stem cell transplant recipients and Triplex. The company was founded by Donald J. Diamond in 2015 and is headquartered in New York, NY.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Cellvation, Inc.
2
| Subsidiary | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Frank Taffy via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| ACCELRYS, INC. | Packaged Software | Corporate Officer/Principal Corporate Officer/Principal | |
| TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Chief Executive Officer | |
| Rochester Christian University | College/University | Undergraduate Degree | |
| KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Founder Chief Executive Officer | |
| FORTRESS BIOTECH, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
StemBioSys, Inc.
 StemBioSys, Inc. BiotechnologyHealth Technology StemBioSys, Inc. develops stem cell technologies. The firm develops technology on the isolation and expansion of specialized adult stem cells for clinical use. Its technology is called XC-marrowECM, which is a patented extracellular matrix laid down by human bone marrow mesenchymal stem cells. The company was founded by Xiao-Dong Chen and Steven A. Davis in 2010 and is headquartered in San Antonio, TX. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of Pennsylvania | College/University | Doctorate Degree | |
| Boston University | College/University | Undergraduate Degree Masters Business Admin | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
| Rutgers State University of New Jersey | College/University | Corporate Officer/Principal | |
| The University of Texas at Austin | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of Chicago | College/University | Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | College/University | Doctorate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree | |
| University of Connecticut | College/University | Graduate Degree | |
Council on Foreign Relations, Inc.
 Council on Foreign Relations, Inc. Investment Trusts/Mutual FundsMiscellaneous Council on Foreign Relations, Inc. provides and disseminates ideas on foreign policies to individuals, corporate members, journalists and policy makers. It operates a forum for government officials, students and other interested parties to study and discuss world issues and impact on American foreign policies. The company publishes Foreign Affairs, a magazine that comes out six times a year, along with books and studies by its own scholars. Council on Foreign Relations was founded in 1921 and is headquartered in New York City, NY. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Texas Research & Technology Foundation
 Texas Research & Technology Foundation BiotechnologyHealth Technology Texas Research & Technology Foundation engages in the operation of economic development in the biosciences and technology. It funds and develops innovative ventures and own and operate the Texas Research Park. The company was founded in 1983 and is headquartered in San Antonio, TX. | Biotechnology | Director/Board Member Director/Board Member Chairman Director/Board Member | |
| GAMIDA CELL LTD. | Pharmaceuticals: Major | Investor Relations Contact | |
Opus Point Partners Management LLC
 Opus Point Partners Management LLC Investment ManagersFinance Opus Point Partners Management LLC (OPPM) is a hedge fund manager headquartered in New York City. The firm was founded by Lindsay Rosenwald and Michael Weiss in 2009. They are owned by Opus Point Partners LLC, which is a subsidiary of Weiss & Co. LLC. OPPM manages investments that are dedicated to healthcare and life science. | Investment Managers | Chief Executive Officer Founder | |
Avraham Pharmaceuticals Ltd.
 Avraham Pharmaceuticals Ltd. BiotechnologyHealth Technology Avraham Pharmaceuticals Ltd. develops pharmaceutical products for prevention and treatment of neurodegenerative disorders. Its lead product candidate, Ladostigil is designed to provide treatment for Mild Cognitive Impairment. The firm’s product candidate is a multifunctional compound that combines neuroprotective mechanisms: reducing oxidative stress and microglial activation, and inhibiting proinflamtory cytokines. The company was founded in 2010 by David Warshawsky and is headquartered in Yavneh, Israel. | Biotechnology | Chief Executive Officer | |
| Columbia Law School | College/University | Graduate Degree Graduate Degree | |
Oracle America, Inc.
 Oracle America, Inc. Information Technology ServicesTechnology Services Oracle America, Inc. provides network computing infrastructure solutions. The company was founded in 1982 and is headquartered in Redwood City, CA. | Information Technology Services | General Counsel | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| ORIGO ACQUISITION CORP | Financial Conglomerates | Chief Executive Officer Chairman | |
| CHECKPOINT THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| AVENUE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
25madison LLC
 25madison LLC Investment ManagersFinance 25madison LLC (25madison) is a venture capital firm founded in 2018 by Steven Price, Matt Fremont Smith, Gary Ginsberg, Kirk Posmantur, Michael Lynton and Lance West. The firm is headquartered in New York. | Investment Managers | Founder Founder | |
Baergic Bio, Inc.
 Baergic Bio, Inc. Pharmaceuticals: MajorHealth Technology Baergic Bio, Inc. develops therapeutic drugs for the treatment of central nervous system disorders. It offers oncology, rare diseases, and gene therapy. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Cyprium Therapeutics, Inc.
 Cyprium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Fortress Biotech, Inc., Cyprium Therapeutics, Inc. is an American New York-based company focused on developing novel therapies for the treatment of Menkes disease and related copper metabolism disorders. The private company was granted FDA breakthrough therapy, fast track, and rare pediatric disease designations, as well as FDA orphan drug designation for both Cutx-101 and AAV-ATP7A. The European Medicines Agency also granted orphan drug designation to Cyprium. In March 2017, Cyprium entered into a cooperative research and development agreement with the Eunice Kennedy Shriver National Institute of Child Health and Human Development to advance the clinical development of Cutx-101 for the treatment of Menkes disease. In 2023, Cyprium completed the transfer of its proprietary rights and assigned its FDA documents pertaining to Cutx-101 to Sentynl Therapeutics, Inc. Cyprium and NICHD also previously entered into a worldwide, exclusive license agreement to develop and commercialize AAV-ATP7A gene therapy, which is currently in pre-clinical development. The company was founded in 2017 by Michael Sean Weiss, Lindsay Allan Rosenwald, and Lung S. Yam, who has been the CEO since then. | Miscellaneous Commercial Services | Founder Founder | |
Caelum Biosciences, Inc.
 Caelum Biosciences, Inc. BiotechnologyHealth Technology Caelum Biosciences, Inc. operates as a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases. The company was founded in January 2017 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
| MUSTANG BIO, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Nimbus Apollo, Inc.
 Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Nimbus Apollo, Inc. provides drug discovery research services. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| MORPHIC HOLDING, INC. | Pharmaceuticals: Major | Director/Board Member | |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Biotechnology | Director/Board Member | |
| STRUCTURE THERAPEUTICS INC. | Miscellaneous Commercial Services | Director/Board Member | |
Oak Hill Bio Corp.
 Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 41 |
| Israël | 4 |
| Verenigd Koninkrijk | 3 |
| Frankrijk | 2 |
| Mexico | 2 |
Sectoraal
| Health Technology | 21 |
| Consumer Services | 15 |
| Commercial Services | 7 |
| Finance | 5 |
| Technology Services | 3 |
Operationeel
| Director/Board Member | 135 |
| Corporate Officer/Principal | 58 |
| Chairman | 40 |
| Founder | 36 |
| Independent Dir/Board Member | 36 |
Sterkste connecties
| Insiders | |
|---|---|
| Michael Lynton | 51 |
| Michael Weiss | 25 |
| Gary Ginsberg | 24 |
| Lindsay Rosenwald | 23 |
| Jeffrey Chodakewitz | 15 |
| Arun Oberoi | 14 |
| Gary Sender | 14 |
| Ramy Farid | 14 |
| Timothy M. Wright | 13 |
| Nancy Thornberry | 12 |
| Bruce B. Barshop | 10 |
| Rosana Kapeller-Libermann | 10 |
| Paul Davie | 9 |
| John W. Feik | 8 |
| Raphael Nir | 8 |
- Beurs
- Insiders
- Frank Taffy
- Bedrijfsconnecties
